Myriad Genetics
MYGN
#7319
Rank
A$0.79 B
Marketcap
A$8.25
Share price
-1.44%
Change (1 day)
-17.39%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2026 (TTM): -A$0.59 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are A$0.82 Billion. In 2025 the company made an earning of -A$0.59 Billion a decrease over its 2024 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.59 Billion0.55%
2025 -A$0.59 Billion218.91%
2024 -A$0.19 Billion-53.49%
2023 -A$0.4 Billion88.72%
2022 -A$0.21 Billion172.08%
2021 -A$76.3 Million
2019 -A$39.74 Million-175.14%
2018 A$52.87 M-70.81%
2017 A$0.18 B22.22%
2016 A$0.14 B-38.8%
2015 A$0.24 B-6.12%
2014 A$0.25 B-41.07%
2013 A$0.43 B46.67%
2012 A$0.29 B15.84%
2011 A$0.25 B17.6%
2010 A$0.21 B-15.96%
2009 A$0.26 B
2007 -A$62.97 Million40.96%
2006 -A$44.67 Million
2003 -A$51.88 Million34.8%
2002 -A$38.49 Million89.21%
2001 -A$20.34 Million3.93%
2000 -A$19.57 Million21.76%
1999 -A$16.08 Million-25.61%
1998 -A$21.61 Million38.83%
1997 -A$15.57 Million-24.26%
1996 -A$20.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
A$10.90 B-1,969.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-A$0.28 Billion-52.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$65.96 M-111.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-A$52.83 Million-90.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A$1.99 B-442.02%๐Ÿ‡บ๐Ÿ‡ธ USA